Anti-obesity Drugs Market Size, Share and Global Report 2023-2028

The latest research study “Anti-obesity Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” by IMARC Group, finds that the global anti-obesity drugs market size reached US$ 2.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.0 Billion by 2028, exhibiting a growth rate (CAGR) of 11.7% during 2023-2028.

Anti-obesity drugs are used to reduce or regulate weight and are generally prescribed by doctors only in cases of morbid obesity. They help control cravings and compulsive eating, especially for sweets, fatty, salty, and calorie-dense foods. They lower the risk of developing severe cardiovascular diseases (CVDs), non-alcoholic fatty liver disease (NAFLD), dangerous lipid levels, waist circumference, blood sugar levels, diabetic kidney disease progression, and high blood pressure. Since they offer numerous health benefits, anti-obesity drugs are gaining immense traction across the globe.

Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/anti-obesity-drugs-market/requestsample

Anti-Obesity Drugs Market Trends and Drivers:

The global anti-obesity drugs market is primarily driven by the rising prevalence of obesity due to sedentary lifestyles. Moreover, the increasing awareness regarding the risk of obesity-associated diseases, such as CVDs, cancer of the esophagus, colon and rectum, liver, gallbladder, pancreas, and kidneys, and type 2 diabetes (T2D) is another major growth-inducing factor.

Besides this, the escalating product demand to promote weight loss that helps improve quality of life, mobility, daily function, and psychological well-being has catalyzed the market growth. Additionally, recent advancements in anti-obesity drugs have enabled the potential to achieve clinically substantial weight loss among individuals. In line with this, the rising regulatory approval of anti-obesity medications (AOMs) to regulate appetite and food cravings is positively influencing market growth.

Other factors, including the rapid expansion in the pharmaceutical industry, increasing focus on managing diseases integrated closely with excess body weight, and rising health consciousness among the masses, are also anticipated to propel the market growth.

Global Anti-Obesity Drugs Market 2023-2028 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Anti-Obesity Drugs Companies:

Binderholz GmbH, Dongwha Enterprise, EGGER Group, Evergreen Fibreboard Berhad, Georgia-Pacific LLC (Koch Industries Inc.), Green River Holding Co. Ltd., Kastamonu Entegre, Louisiana-Pacific Corporation, Sonae Arauco, Starbank Panel Products Ltd., West Fraser Timber Co. Ltd. and Weyerhaeuser Company.

The report has segmented the market on the basis of region, drug class, drug type and distribution channel.

Breakup by Drug Class:

• Peripherally Acting Drugs
• Centrally Acting Drugs

Breakup by Drug Type:

• Prescription Drugs
• OTC Drugs

Breakup by Distribution Channel:

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Breakup by Region:

• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=5544&flag=C

If you want latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

 Key highlights of the report:

• Market Performance (2017-2022)
• Market Outlook (2023- 2028)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Services Private Limited.
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800